Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.045 USD | +1.63% | -4.43% | -29.29% |
May. 30 | Monte Rosa Therapeutics Names Three Insiders to Leadership Team | MT |
May. 30 | Monte Rosa Therapeutics, Inc. Announces Executive Promotions | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.29% | 243M | |
+46.05% | 56.65B | |
-6.88% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.37% | 26.75B | |
-21.01% | 19.03B | |
+0.88% | 12.28B | |
+24.48% | 12.26B | |
+27.04% | 12.04B |
- Stock Market
- Equities
- GLUE Stock
- News Monte Rosa Therapeutics, Inc.
- UBS Adjusts Monte Rosa Therapeutics Price Target to $20 From $22, Maintains Buy Rating